Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oncology drugs
Biotech
A 5-month sprint: Inside Pfizer's $10B deal with Innovent
Leveraging interest from other parties, Innovent at one point threatened to walk away if Pfizer didn’t agree to its co-development terms.
Angus Liu
Jun 21, 2026 10:41pm
Pfizer pens $10B, 12-drug deal with Innovent
May 29, 2026 4:05am
Fierce Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
May 11, 2026 10:22am
How Jeff Legos builds Pfizer’s oncology future
Mar 4, 2026 2:00pm
Cullinan puts kibosh on 2 cancer assets amid autoimmune refocus
Nov 6, 2025 1:26pm
Karyopharm lays off 20% of staffers amid hunt for alternatives
Jul 11, 2025 11:02am
